Condition: Breast Cancer · Sponsor: Omphis Foundation
The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
This description comes directly from the study's public registry record.
Sandra Lopez gordo · 0034660284047 · sandra.lopezgordo@gmail.com
Sandra Lopez gordo · 660284047 · sandra.lopezgordo@gmail.com
Always discuss trial participation with your own doctor first.
| Sandra Lopez Gordo | Cerdanyola del Vallès, Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06378944